These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 17635753

  • 1. Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
    Tanaka H, Oki ES, Tsugawa K, Suzuki K, Tsuruga K, Ito E.
    Nephrology (Carlton); 2007 Aug; 12(4):376-9. PubMed ID: 17635753
    [Abstract] [Full Text] [Related]

  • 2. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 3. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 Jul; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 4. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 5. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 6. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X, Gu F, Chen W, Liu Y, Wei H, Liu L, Yin S, Da Z, Sun L.
    Chin Med J (Engl); 2014 Dec; 127(21):3718-23. PubMed ID: 25382325
    [Abstract] [Full Text] [Related]

  • 7. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S.
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 9. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E.
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [Abstract] [Full Text] [Related]

  • 10. Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis.
    Tanaka H, Oki E, Tsuruga K, Aizawa-Yashiro T, Ito Y, Sato N, Kawasaki Y, Suzuki J.
    Clin Rheumatol; 2010 Sep; 29(9):1049-54. PubMed ID: 20490589
    [Abstract] [Full Text] [Related]

  • 11. Long-term mizoribine intermittent pulse therapy, but not azathioprine therapy, attenuated histologic progression in a patient with severe lupus nephritis.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Waga S, Ito E.
    Clin Nephrol; 2007 Sep; 68(3):198-200. PubMed ID: 17915627
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
    Nishi E, Kameda H, Ogawa H, Nagasawa H, Takei H, Okuyama A, Kurasawa T, Kondo T, Nishimura K, Shirai Y, Sakai R, Ito T, Takeuchi T, Amano K.
    Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
    Yoshidome K, Takei S, Imanaka H, Maeno N, Ohkawa T, Kawano Y.
    Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 15. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y, Fukuda W, Kawahito Y, Kohno M, Wada M, Ishino H, Hamaguchi M, Yamamoto A, Kadoya M, Niimi M, Yoshikawa T.
    Mod Rheumatol; 2008 Jul; 18(1):91-5. PubMed ID: 18159569
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S, Kaneko K, Ohtomo Y, Murakami H, Takada M, Akashi S, Hira M, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [Abstract] [Full Text] [Related]

  • 18. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, Ito E.
    Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
    [Abstract] [Full Text] [Related]

  • 19. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
    Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M.
    Pediatr Int; 2006 Apr; 48(2):152-7. PubMed ID: 16635174
    [Abstract] [Full Text] [Related]

  • 20. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
    Zhang M, Xing CY, Liu J.
    Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.